MarketPeel
Insider Trading Intelligence
CG

Carl L. Gordon

ORIC
DIRECTOR · ORIC PHARMACEUTICALS, INC. · CIK 0001282930
FILING MIX · LIFETIME65%/35%
BUYS
88
SELLS
47
TOTAL VALUE
$124.91M
COMPANIES
8
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
19,449,634
AVG SELL PX
$7.76
TRADE KIND
SHOWING 135 / 135
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
33 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Carl L. Gordon, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d33+66.67%+5.19%-0.14%+5.33%-0.70%1.40
14d33+69.70%+4.96%-0.33%+5.28%-9.71%1.14
30d33+72.73%+5.99%+1.25%+4.74%-4.06%0.93
60d33+69.70%+9.16%+0.95%+8.21%-10.84%1.30
90d33+45.45%-10.15%+4.10%-14.25%-22.62%-2.98
180d33+63.64%+14.99%+8.13%+6.87%-13.60%0.56
1y33+63.64%-24.78%+16.05%-40.83%-73.36%-3.45
2y33(2 pending)+61.29%-38.63%+30.58%-69.21%-85.66%-6.44
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORIC · 16,625 shares · as of Jun 16, 2021
0691,4291,382,8592,074,2882,765,7172021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 88 buys / 47 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,00090,000Jan 2, 2026Jan 5, 2026View →
KROS
KEROS THERAPEUTICS, INC.
SALE
140,057$17.75$2.49M759,155Nov 21, 2025Dec 18, 2025View →
KROS
KEROS THERAPEUTICS, INC.
SALE
74,465$17.75$1.32M45,057Nov 21, 2025Dec 18, 2025View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,50010,500Jun 4, 2025Jun 6, 2025View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,2505,250Jun 4, 2025Jun 6, 2025View →
CMPX
COMPASS THERAPEUTICS, INC.
SALE
3,571,428$1.59$5.68M0Apr 9, 2025Apr 11, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
94,100$10.84$1.02M747,887Feb 18, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
49,070$10.84$531.9K3,255,000Feb 18, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
29,540$9.85$291.0K3,205,930Feb 14, 2025Feb 19, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
17,962$9.90$177.8K3,176,390Feb 14, 2025Feb 19, 2025View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 11, 2025Feb 13, 2025View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
403,787403,787Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
2,658,4282,658,428Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
4,854,3680Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
12,372,6340Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
250,000$16.00$4.00M653,787Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASE
500,000$16.00$8.00M3,158,428Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
SALE
19,587,2840Sep 16, 2024Sep 17, 2024View →
MBX
MBX BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
15,96315,963Sep 12, 2024Sep 13, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
26,4000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
18,5000Aug 21, 2024Aug 23, 2024View →
ACET
ADICET BIO, INC.
SALE
30,0000Aug 21, 2024Aug 23, 2024View →
KROS
KEROS THERAPEUTICS, INC.
SALE
220,600$44.01$9.71M899,212Aug 13, 2024Aug 15, 2024View →
KROS
KEROS THERAPEUTICS, INC.
SALE
29,400$44.01$1.29M119,522Aug 13, 2024Aug 15, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
556$10.00$5.6K1,967,924Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,009$10.00$40.1K4,839,412Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
623$10.00$6.2K755,635Jul 16, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,401$10.00$54.0K1,968,480Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
6,142$10.00$61.4K756,258Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,433$10.00$394.3K4,843,421Jul 15, 2024Jul 17, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
4,6764,676Jul 1, 2024Jul 2, 2024View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 10, 2024Jun 14, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
5,90011,800Jun 5, 2024Jun 7, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Jun 5, 2024Jun 7, 2024View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000May 30, 2024Jun 3, 2024View →
PHGE
BIOMX INC.
SALE
9,280,4080May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
9,280,408$0.24$2.26M13,797,997May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
SALE
24,344$0.38$9.3K13,773,653May 15, 2024May 20, 2024View →
PHGE
BIOMX INC.
PURCHASE
2,163,5002,163,500Mar 15, 2024Mar 19, 2024View →
PHGE
BIOMX INC.
PURCHASE
4,3274,327Mar 15, 2024Mar 19, 2024View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 9, 2024Feb 14, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
821,827821,827Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
469,6150Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
SALE
821,8270Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
469,6151,291,442Jan 30, 2024Jan 31, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASE
222,222$18.00$4.00M1,513,664Jan 30, 2024Jan 31, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,841,100$2.40$4.42M7,526,359Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
242,200$2.40$581.3K990,254Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASE
1,041,700$2.40$2.50M1,255,985Jan 25, 2024Jan 26, 2024View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
26,4000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
18,5000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
SALE
30,0000Aug 14, 2023Aug 16, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
250,000$2.09$522.5K646,657Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
125,000$2.09$261.3K1,027,885Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
58,000$2.09$121.2K748,054Jun 27, 2023Jun 29, 2023View →
ACET
ADICET BIO, INC.
PURCHASE
442,000$2.09$923.8K5,685,259Jun 27, 2023Jun 29, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 12, 2023Jun 14, 2023View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
10,00010,000Jun 6, 2023Jun 8, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
26,40026,400Jun 1, 2023Jun 2, 2023View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
5,9005,900Jun 1, 2023Jun 2, 2023View →
PHGE
BIOMX INC.
PURCHASE
348,000$0.25$85.3K3,161,489Feb 27, 2023Mar 17, 2023View →
PHGE
BIOMX INC.
PURCHASE
1,789,9591,789,959Feb 27, 2023Mar 17, 2023View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,00060,000Feb 8, 2023Feb 9, 2023View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
137,931$7.25$1000.0K4,882,854Dec 23, 2022Dec 28, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
402,000$3.21$1.29M15,219,994Nov 8, 2022Nov 10, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
64,05064,050Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
457,400$2.42$1.11M1,973,881Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
2,470,200$2.42$5.98M4,744,923Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
762,400$2.42$1.85M762,400Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
207,500207,500Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
38,45038,450Aug 16, 2022Aug 18, 2022View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
32,00032,000Jun 16, 2022Jun 21, 2022View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Jun 2, 2022Jun 3, 2022View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,2938,293Jun 1, 2022Jun 3, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
30,722$2.49$76.5K14,817,994May 13, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
97,094$2.35$228.2K14,787,272May 12, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
64,700$1.79$115.8K14,690,178May 11, 2022May 13, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
24,447$1.60$39.1K14,625,478May 10, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
90,712$1.56$141.5K14,601,031May 9, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
10,200$1.63$16.6K14,510,319May 6, 2022May 10, 2022View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
30,00030,000Feb 18, 2022Feb 23, 2022View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
214,285$14.00$3.00M242,285Dec 10, 2021Dec 14, 2021View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
3,571,428$3.50$12.50M3,571,428Nov 4, 2021Nov 8, 2021View →
CMPX
COMPASS THERAPEUTICS, INC.
PURCHASE
1,785,715$3.50$6.25M14,500,119Nov 4, 2021Nov 8, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,62516,625Jun 16, 2021Jun 17, 2021View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,2938,293Jun 1, 2021Jun 3, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
18,50018,500Apr 30, 2021May 4, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
27,869$23.93$666.9K2,212,571Mar 30, 2021Mar 31, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
75,555$23.31$1.76M2,240,440Mar 29, 2021Mar 31, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
27,816$23.88$664.2K2,315,995Mar 26, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
51,523$24.70$1.27M2,343,811Mar 25, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
32,959$24.80$817.4K2,395,334Mar 24, 2021Mar 26, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
3,992$24.32$97.1K2,428,293Mar 23, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
7,673$26.47$203.1K2,432,285Mar 22, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
21,275$26.47$563.1K2,439,958Mar 19, 2021Mar 23, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
6,059$28.03$169.8K2,461,233Mar 18, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
18,790$28.43$534.2K2,467,292Mar 17, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
41,353$27.72$1.15M2,486,082Mar 16, 2021Mar 18, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
89,210$29.14$2.60M2,527,435Mar 15, 2021Mar 15, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
90,521$30.29$2.74M2,616,645Mar 12, 2021Mar 15, 2021View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
58,551$33.04$1.93M2,707,166Mar 11, 2021Mar 15, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,00025,000Feb 24, 2021Feb 26, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
104,050$13.00$1.35M396,657Feb 12, 2021Feb 18, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
420,299$13.00$5.46M5,243,259Feb 12, 2021Feb 18, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,326,4811,326,481Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
1,071,4280Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
918,2950Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,989,7231,989,723Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
285,000$17.00$4.84M2,274,723Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
612,1960Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
190,000$17.00$3.23M1,516,481Feb 9, 2021Feb 9, 2021View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
714,2850Feb 9, 2021Feb 9, 2021View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
30,00030,000Sep 17, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
4,822,9604,822,960Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
292,607292,607Sep 15, 2020Sep 17, 2020View →
ACET
ADICET BIO, INC.
PURCHASEGRANT
Stock grant
902,885902,855Sep 15, 2020Sep 17, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
373,3562,529,606Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
373,3560Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
236,1112,765,717Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
1,875,0002,156,250Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
1,875,0000Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
236,1110Apr 28, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
281,250$16.00$4.50M281,250Apr 24, 2020Apr 28, 2020View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,62516,625Apr 23, 2020Apr 27, 2020View →
KROS
KEROS THERAPEUTICS, INC.
SALE
744,6120Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
SALE
148,9220Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
148,922148,922Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
744,612744,612Apr 13, 2020Apr 13, 2020View →
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
375,200$16.00$6.00M1,119,812Apr 13, 2020Apr 13, 2020View →
Other insiders · ORIC
Loading peer insiders…
About this filer
CIK 0001282930
ROLE
Director
PRIMARY
ORIC
COMPANIES
8
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001282930DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback